Form 8-K - Current report:
SEC Accession No. 0001555280-22-000026
Filing Date
2022-02-08
Accepted
2022-02-08 16:19:18
Documents
14
Period of Report
2022-02-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zts-20220208.htm   iXBRL 8-K 37289
2 EX-99.1 exhibit9912022q2dividend2-.htm EX-99.1 11850
6 GRAPHIC imagea.jpg GRAPHIC 10748
  Complete submission text file 0001555280-22-000026.txt   204161

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zts-20220208.xsd EX-101.SCH 1971
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zts-20220208_lab.xml EX-101.LAB 24224
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zts-20220208_pre.xml EX-101.PRE 12664
8 EXTRACTED XBRL INSTANCE DOCUMENT zts-20220208_htm.xml XML 10929
Mailing Address 10 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 10 SYLVAN WAY PARSIPPANY NJ 07054 973-822-7000
Zoetis Inc. (Filer) CIK: 0001555280 (see all company filings)

EIN.: 460696167 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35797 | Film No.: 22601846
SIC: 2834 Pharmaceutical Preparations